7.45M
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.

Similar securities

Based on sector and market capitalization

Report issue